Keywords: novartis, breast, cancer, drug, femara, trial, halted

Novartis' breast cancer drug Femara trial halted due to good results

Article | 20 October 2003

Print This

A 43% reduction in the risk of breast cancer recurrence and a 46% cut in disease spreading from one breast to the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in